Vaginitis Treatment Drug Market Size & Trends 2025-2035

Future Market Insights

Vaginitis Treatment Drug Market

Key Insight

Vaginitis treatment drug sales will expand through 2035, with nitroimidazole compounds at 44.1% of drug sales and bacterial vaginosis at 51.8% within the indication segment in 2025. The market was valued at USD 3.49 billion in 2025 and is forecast to record a 4.8% CAGR between 2025 and 2035.

July 28, 2025

Anurag Sharma

315 Pages

Cite this Report

Vaginitis Treatment Drug Market

https://www.futuremarketinsights.com/reports/vaginitis-treatment-drugs-market

License

Buy Now

Summary ToC Companies

Key Players

Allergan plc
BlackRock
Bayer
Cipla Ltd
Dr. Reddy’s Laboratories
GSK
The Vanguard Group
Merck KGaA
Mylan
Novartis
L'Oréal
Sun Pharmaceutical Industries Ltd
Berkshire Hathaway

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Vaginitis Treatment Drug Market

Key Players

Similar Industry Reports